The Current Ratio as of November 2024 (TTM) for Venus Concept Inc. (VERO) is 1.86

According to Venus Concept Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.86. This represents a change of -7.37% compared to the average of 2.01 of the last 4 quarters.

Venus Concept Inc. (VERO) Historical Current Ratio (quarterly & annually)

How has VERO Current Ratio performed in the past?

The mean historical Current Ratio of Venus Concept Inc. over the last ten years is 2.80. The current 1.86 Current Ratio has changed 6.56% with respect to the historical average. Over the past ten years (40 quarters), VERO's Current Ratio was at its highest in in the September 2018 quarter at 4.24. The Current Ratio was at its lowest in in the September 2016 quarter at 0.

Venus Concept Inc. (VERO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Venus Concept Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Venus Concept Inc. (VERO) Average Current Ratio

How has VERO Current Ratio performed in the past?

The current Current Ratio of Venus Concept Inc. (VERO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Venus Concept Inc. (VERO) Current Ratio vs. Peers

How is VERO’s Current Ratio compared to its peers?

Venus Concept Inc.’s Current Ratio is greater than Aziyo Biologics, Inc. (0.87), greater than Ainos, Inc. (1.37), less than Surmodics, Inc. (3.96), less than LENSAR, Inc. (3.37), greater than IRIDEX Corporation (1.54), less than CVRx, Inc. (11.32), less than Inogen, Inc. (2.66), less than Orthofix Medical Inc. (2.39), less than Establishment Labs Holdings Inc. (3.62), less than NeuroPace, Inc. (5.59), less than Sight Sciences, Inc. (10.18), greater than STRATA Skin Sciences, Inc. (1.13), greater than Vapotherm, Inc. (0.25), less than Talis Biomedical Corporation (7.76), less than Bone Biologics Corporation (14.87), less than Bluejay Diagnostics, Inc. (6.26), less than Nuwellis, Inc. (2.03), less than Heart Test Laboratories, Inc. (4.00), greater than Accelerate Diagnostics, Inc. (1.50), less than Anika Therapeutics, Inc. (5.34), less than AxoGen, Inc. (3.74),

Build a custom stock screener for Venus Concept Inc. (VERO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Venus Concept Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Venus Concept Inc. (VERO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Venus Concept Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.